BCL2L1 and breast carcinoma: Importantly, Bcl-xL-overexpression was also observed in N-Cadherin-positive, singly migrating breast cancer cells at the invasive front in clinical samples, suggesting that the association of Bcl-xL overexpression and EMT might be a common occurrence in breast carcinoma.